Filing Flows › Geron (GERN) › R&D spending
Geron (GERN) R&D spending by quarter
Geron's R&D spending was $12.7M in Q3 2026 (third quarter 2026), -42% from Q2 2026. Over the last 6 quarters it ranged from $12.7M (Q3 2026) to $22.0M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $12.7M | -42% | -40% |
| Q2 2026 | $22.0M | +47% | +1% |
| Q1 2026 | $15.0M | -29% | -0.8% |
| Q3 2025 | $21.1M | -3% | — |
| Q2 2025 | $21.7M | +44% | — |
| Q1 2025 | $15.1M | — | — |
Q3 2026 at a glance
Geron, Q3 2026: revenue $60.2M (+27% year over year), operating margin 9.6%, net earnings $1.4M, operating cash flow $10.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Geron's R&D spending?
Geron's R&D spending was $12.7M in Q3 2026 (third quarter 2026), -42% from Q2 2026.
How has Geron's R&D spending changed?
Over the last 6 quarters it ranged from $12.7M (Q3 2026) to $22.0M (Q2 2026).